Clinical evaluation of the product by design surgeons completed, driving early commercial momentum SALT LAKE CITY, Utah, Nov. 03, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ...
Dr. Mehmet Oz and Dr. Marty Makary touted that reducing steps for biosimilar approval will lower costs by increasing competition.
Xcellon Biologics will incorporate IntoCell’s OHPAS drug-linker system into its range of ADC development suites.
Developers of biosimilars, medicines that are near-identical copies of biologic drugs, will no longer be required to conduct clinical trials to prove effectiveness.
Laws focused lowering drug prices have expanded in 15 states, with new boards and payment limits shaping affordability since 2017.
Viridian seeks Priority Review for veligrotug, aiming for a potential mid-2026 commercial launch if approved. Global phase 3 ...
Vinay Prasad, chief of the FDA’s Center for Biologics Evaluation and Research, is planning to publish a paper this month to ...
On Wednesday, Oct. 29, the Food and Drug Administration (FDA) issued draft guidance proposing to update its biosimilar review framework. Under the ...
Opinion
11hOpinion
DR. MAKARY, DR OZ: People talk about lowering health care costs, but the Trump administration is doing it
FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug costs by removing extra clinical trial requirements.
All over the world people are ageing more rapidly and succumbing to diseases that typically affected the elderly. But there are ways to turn back the clock on your biological age ...
Learn how labman is advancing biologics manufacturing through AI-powered bioreactor technology, driving innovation in drug ...
Dr. Vinay Prasad, who oversees FDA’s vaccine and biologics center, resigned in July after coming under fire from conservative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback